History
The Charnwood Campus carries a huge legacy in pharmaceutical research and development.
World-Class Campus In the Heart of the UK
1930
Fisons (which dated back to the 1700s) . Fisons bought a part share in the then Loughborough-based company Genatosan, manufacturers of Sanatogen nerve tonic.
A Genatosan delivery vehicle, outside Loughborough Park Gates, 1924
New Genatosan research laboratories open in Loughborough September 1939
Staff at the opening ceremony of Genatosan Ltd new laboratories on Derby Road, 14th September 1939
1950
The significant discovery of INTAL, a fundamentally new approach to asthma therapy, was well under way during the 1950s and was marketed in 1968.
The Genetosan Laboratories in Loughborough circa 1955
Dr Roger Altounyan
An original spinhaler, disassembled and loaded with a capsule of INTAL, together with carry case
1960
Construction of new research and manufacturing buildings was completed at Bakewell Road. The discovery and development of a second inhaled compound was subsequently marketed as TILADE. Other projects were started with significant compounds being discovered and also the discovery of DOPACARD.
Fisons new R&D laboratories, Bakewell Road Loughborough circa 1988
Fisons new R&D laboratories, Bakewell Road Loughborough circa 1988
Fisons new R&D laboratories, Bakewell Road Loughborough circa 1988
1980
Modernisation and expansion programme with the building of the pharmacology building.
New pharmacology Building (opened January 1990)
Sam Orr, Head of Discovery (left) and Fisons Chairman John Kerridge, Lay the opening plaque for the new pharmacology building at Fisons Pharmaceuticals R&D site at Bakewell Road Loughborough on 21st June 1988
1990
Expansion with the building of the Biology and Chemistry facilities.
New research buildings at Astra Charnwood, Loughborough 1995
Astra AB Headquarters Södertälje, Sweden
John Dixon, Fisons Director of Research (right) showing Prime Minister John Major the new Chemistry laboratories, 1993
2000
Fisons bought by Astra. Merged with Zeneca of Sweden to form Astrazeneca.
AstraZeneca PLC Chief Executive Officer Tom McKillop, and Executive Director of Research and Development Claes Wilhelmson at Charnwood, shortly after the formation of AstraZeneca.
Simon Proffit, Charnwood Site Head, David Brennan, AstraZeneca Chief Executive Officer, and John Dixon, Head of Discovery unveil the sculpture commissioned to mark the opening of the new Biology building, 2006
2013
Charnwood Campus Formed.
2014
Close cooperation with Charnwood Council, Leicester City Council, Medilink East Midlands, LLEP, Business Innovation & Skills, and Office for Life Sciences resulted in firming up Charnwood Campus Investment and Implementation Strategy.
2015
First tenants on the campus
ARM
ARM specializes in developing truly cutting edge, next generation camera and display subsystems, bringing deep knowledge of human visual processing to create the best possible image quality and new user experiences.
Almac Group
Almac is a contract research organisation based in Craigavon, Northern Ireland. The company employs about 3,300 in the United Kingdom and United States. Almac provides integrated drug development services, research, and manufacturing to about 600 clients world-wide within diagnostics, sciences, clinical services, clinical technologies and pharmaceutical sectors. It was founded in 1968 as Galen by the late Sir Allen McClay.